Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Alexopoulou

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Hepatology|January 1, 1993
Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinomaS J Hadziyannis, G Giannoulis, E Hadziyannis, et al.
Hepatology (Baltimore, Md.)|December 1, 1995
Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factorsP Karayiannis, A Alexopoulou, S Hadziyannis, et al.
Journal of Hepatology|October 9, 1998
Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis BA Alexopoulou, A M Owsianka, G Kafiri, et al.
Journal of Viral Hepatitis|August 16, 2006
Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutationsA Alexopoulou, M Theodorou, S P Dourakis, et al.
Journal of Viral Hepatitis|July 1, 1996
Whole genome analysis of hepatitis B virus from four cases of fulminant hepatitis: genetic variability and its potential role in disease pathogenicityA Alexopoulou, P Karayiannis, S J Hadziyannis, et al.
European Journal of Internal Medicine|July 20, 2014
The role of tenofovir in preventing and treating hepatitis B virus (HBV) reactivation in immunosuppressed patients. A real life experience from a tertiary centerJ S Koskinas, M Deutsch, S Adamidi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 2017
Intestinal colonization with resistant bacteria: a prognostic marker of mortality in decompensated cirrhosisS Pouriki, G Vrioni, H Sambatakou, et al.
Scandinavian Journal of Gastroenterology|August 27, 2022
Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?Panagiotis V Katsaounis, Emilia S Hadjiyannis, Teressa Skaltsi, et al.
Cardiovascular and Interventional Radiology|January 18, 2023
Safety, Efficacy and Distribution of Doxorubicin Loaded Radiopaque Beads in Chemoembolization in Intermediate Stage Hepatocellular Carcinoma (HCC) with Correlation with Local ResponseΚ Malagari, Th Kiakidis, Hip Moschouris, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Hepatology|January 1, 1993
Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinomaS J Hadziyannis, G Giannoulis, E Hadziyannis, et al.
Hepatology (Baltimore, Md.)|December 1, 1995
Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factorsP Karayiannis, A Alexopoulou, S Hadziyannis, et al.
Journal of Hepatology|October 9, 1998
Core variability does not affect response to interferon alpha in HBeAg negative chronic hepatitis BA Alexopoulou, A M Owsianka, G Kafiri, et al.
Journal of Viral Hepatitis|August 16, 2006
Hepatitis B virus reactivation in patients receiving chemotherapy for malignancies: role of precore stop-codon and basic core promoter mutationsA Alexopoulou, M Theodorou, S P Dourakis, et al.
Journal of Viral Hepatitis|July 1, 1996
Whole genome analysis of hepatitis B virus from four cases of fulminant hepatitis: genetic variability and its potential role in disease pathogenicityA Alexopoulou, P Karayiannis, S J Hadziyannis, et al.
European Journal of Internal Medicine|July 20, 2014
The role of tenofovir in preventing and treating hepatitis B virus (HBV) reactivation in immunosuppressed patients. A real life experience from a tertiary centerJ S Koskinas, M Deutsch, S Adamidi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 2017
Intestinal colonization with resistant bacteria: a prognostic marker of mortality in decompensated cirrhosisS Pouriki, G Vrioni, H Sambatakou, et al.
Scandinavian Journal of Gastroenterology|August 27, 2022
Bone disease in patients with cirrhosis of different etiology and severity; are Klotho protein and osteoprotegerin potential biomarkers?Panagiotis V Katsaounis, Emilia S Hadjiyannis, Teressa Skaltsi, et al.
Cardiovascular and Interventional Radiology|January 18, 2023
Safety, Efficacy and Distribution of Doxorubicin Loaded Radiopaque Beads in Chemoembolization in Intermediate Stage Hepatocellular Carcinoma (HCC) with Correlation with Local ResponseΚ Malagari, Th Kiakidis, Hip Moschouris, et al.
Pageof 2